PARSIPPANY, N.J.--(BUSINESS WIRE)--Fidia Farmaceutici S.p.A., a world leader in the research, development and manufacturing of hyaluronan (HA) - based products and its wholly owned subsidiary, Fidia ...

HYMOVIS ® is a highly viscoelastic, non-crosslinked hydrogel bioengineered using a proprietary process that increases lubrication and shock absorption properties and results in a natural hyaluronan ...

Please provide your email address to receive an email when new articles are posted on . Fidia Pharma USA Inc. announced CMS has given Hymovis a unique J-code. According to a company press release, the ...